<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35892064</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0973-3930</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>International journal of diabetes in developing countries</Title><ISOAbbreviation>Int J Diabetes Dev Ctries</ISOAbbreviation></Journal><ArticleTitle>Persistence of new-onset diabetes in the post-acute phase of COVID-19.</ArticleTitle><Pagination><StartPage>118</StartPage><EndPage>119</EndPage><MedlinePgn>118-119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13410-022-01119-7</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sathish</LastName><ForeName>Thirunavukkarasu</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-2016-4964</Identifier><AffiliationInfo><Affiliation>Department of Family and Preventive Medicine, Emory University, Atlanta, GA 30322 USA.</Affiliation><Identifier Source="GRID">grid.189967.8</Identifier><Identifier Source="ISNI">0000 0001 0941 6502</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anton</LastName><ForeName>Mary Chandrika</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu India.</Affiliation><Identifier Source="GRID">grid.444347.4</Identifier><Identifier Source="ISNI">0000 0004 1796 3866</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Int J Diabetes Dev Ctries</MedlineTA><NlmUniqueID>101285656</NlmUniqueID><ISSNLinking>1998-3832</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">long-covid</Keyword><Keyword MajorTopicYN="N">new-onset diabetes</Keyword></KeywordList><CoiStatement>Competing interestsThe authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>2</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35892064</ArticleId><ArticleId IdType="pmc">PMC9302869</ArticleId><ArticleId IdType="doi">10.1007/s13410-022-01119-7</ArticleId><ArticleId IdType="pii">1119</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Madhu SV. Post-COVID diabetes care &#x2013; lessons and challenges. Int J Diabetes Dev Ctries 2020;40(2)15:155-157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271952</ArticleId><ArticleId IdType="pubmed">32837089</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis. Diabetes Obes Metab. 2021;23(3):870&#x2013;874. doi: 10.1111/dom.14269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14269</ArticleId><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Farag AA, Hassanin HM, Soliman HH, Sallam A, Sediq AM, Elbaser ESA. Newly Diagnosed Diabetes in Patients with COVID-19: Different Types and Short-Term Outcomes. Trop Med Infect Dis. 2021;6(3):142. doi: 10.3390/tropicalmed6030142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed6030142</ArticleId><ArticleId IdType="pmc">PMC8396224</ArticleId><ArticleId IdType="pubmed">34449740</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, Ben Nasr M, D'Addio F, Loretelli C, Rossi A, Pastore I, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3(6):774&#x2013;785. doi: 10.1038/s42255-021-00407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Cromer SJ, Colling C, Schatoff D, Leary M, Stamou MI, Selen DJ, et al. Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes. J Diabetes Complications. 2022;36(4):108145. doi: 10.1016/j.jdiacomp.2022.108145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2022.108145</ArticleId><ArticleId IdType="pmc">PMC8813764</ArticleId><ArticleId IdType="pubmed">35148936</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>